Clinical Laserthermia Systems AB (publ)

OM:CLS B Stock Report

Market Cap: SEK 83.6m

Clinical Laserthermia Systems Management

Management criteria checks 3/4

Clinical Laserthermia Systems' CEO is Dan Mogren, appointed in Dec 2020, has a tenure of 3.92 years. total yearly compensation is SEK2.17M, comprised of 76.3% salary and 23.7% bonuses, including company stock and options. directly owns 0.075% of the company’s shares, worth SEK62.56K. The average tenure of the management team and the board of directors is 2.8 years and 3.6 years respectively.

Key information

Dan Mogren

Chief executive officer

SEK 2.2m

Total compensation

CEO salary percentage76.3%
CEO tenure3.9yrs
CEO ownership0.07%
Management average tenure2.8yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

We Think Clinical Laserthermia Systems (STO:CLS B) Needs To Drive Business Growth Carefully

Jan 03
We Think Clinical Laserthermia Systems (STO:CLS B) Needs To Drive Business Growth Carefully

Will Clinical Laserthermia Systems (STO:CLS B) Spend Its Cash Wisely?

Aug 26
Will Clinical Laserthermia Systems (STO:CLS B) Spend Its Cash Wisely?

Clinical Laserthermia Systems (STO:CLS B) Is Making Moderate Use Of Debt

Mar 01
Clinical Laserthermia Systems (STO:CLS B) Is Making Moderate Use Of Debt

CEO Compensation Analysis

How has Dan Mogren's remuneration changed compared to Clinical Laserthermia Systems's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 64m

Jun 30 2024n/an/a

-SEK 68m

Mar 31 2024n/an/a

-SEK 71m

Dec 31 2023SEK 2mSEK 2m

-SEK 80m

Sep 30 2023n/an/a

-SEK 63m

Jun 30 2023n/an/a

-SEK 77m

Mar 31 2023n/an/a

-SEK 78m

Dec 31 2022SEK 1mSEK 1m

-SEK 71m

Sep 30 2022n/an/a

-SEK 81m

Jun 30 2022n/an/a

-SEK 63m

Mar 31 2022n/an/a

-SEK 68m

Dec 31 2021SEK 2mSEK 1m

-SEK 64m

Compensation vs Market: Dan's total compensation ($USD202.34K) is about average for companies of similar size in the Swedish market ($USD244.41K).

Compensation vs Earnings: Dan's compensation has increased whilst the company is unprofitable.

CEO

Dan Mogren (60 yo)

3.9yrs

Tenure

SEK 2,174,979

Compensation

Mr. Dan Johansson Mogren was Acting Chief Executive Officer at Clinical Laserthermia Systems AB (publ) since December 01, 2020 until May 2022 and is Chief Executive Officer May 2022 and served as its Chief...

Leadership Team

NamePositionTenureCompensationOwnership
Dan Mogren
Chief Executive Officer3.9yrsSEK 2.17m0.075%
SEK 62.6k
Lars-Erik Eriksson
Co-Founder & Directorno dataSEK 125.00kno data
Hakan Rosqvist
Interim Chief Financial Officerless than a yearno datano data
Jimmy Johansson
Executive Vice President of Operations1.5yrsno data0.0014%
SEK 1.2k
Cristina Pantaleone
Chief Technical Officer2.8yrsno datano data
Liselotte Nilsson
Vice President of Marketing3.8yrsno data0.0047%
SEK 3.9k

2.8yrs

Average Tenure

56yo

Average Age

Experienced Management: CLS B's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lars-Erik Eriksson
Co-Founder & Director18.8yrsSEK 125.00kno data
Stephan Dymling
Member of Clinical Advisory Boardno dataSEK 125.00k0.0078%
SEK 6.5k
Hans Von Celsing
Independent Directorno dataSEK 250.00k0.0036%
SEK 3.0k
Rolf Kiessling
Member of Clinical Advisory Board3.4yrsSEK 80.00kno data
Karl-Göran Tranberg
Member of Clinical Advisory Board3.4yrsSEK 80.00kno data
Paolo Raffaelli
Independent Director3.8yrsSEK 125.00k0.00072%
SEK 602.0
Marika Crohns
Independent Director & Member of Clinical Advisory Board4.8yrsSEK 125.00k0.0070%
SEK 5.8k
Sandy Brandmeier
Independent Director3.8yrsSEK 125.00k0.013%
SEK 10.7k
Peter Mantas
Directorless than a yearno datano data
Peter Max
Chairman of the Boardless than a yearno datano data

3.6yrs

Average Tenure

71.5yo

Average Age

Experienced Board: CLS B's board of directors are considered experienced (3.6 years average tenure).